330 related articles for article (PubMed ID: 9714974)
61. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
Garland SM; Sellors JW; Wikstrom A; Petersen CS; Aranda C; Aractingi S; Maw RD;
Int J STD AIDS; 2001 Nov; 12(11):722-9. PubMed ID: 11589811
[TBL] [Abstract][Full Text] [Related]
62. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
Gayed SL
Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
[TBL] [Abstract][Full Text] [Related]
63. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
[TBL] [Abstract][Full Text] [Related]
64. Human leukocyte interferon-alpha in cream, for the treatment of genital warts in Asian women: a placebo-controlled, double-blind study.
Syed TA; Lundin S; Cheema KM; Kahlon BM; Cheema R; Ahmad SA; Ahmad M
Clin Investig; 1994 Nov; 72(11):870-3. PubMed ID: 7894214
[TBL] [Abstract][Full Text] [Related]
65. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
Schöfer H
Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
[TBL] [Abstract][Full Text] [Related]
67. Female genital warts: global trends and treatments.
Gall SA
Infect Dis Obstet Gynecol; 2001; 9(3):149-54. PubMed ID: 11516064
[TBL] [Abstract][Full Text] [Related]
68. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
Moresi JM; Herbert CR; Cohen BA
Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
[TBL] [Abstract][Full Text] [Related]
69. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis.
Gotovtseva EP; Kapadia AS; Smolensky MH; Lairson DR
Sex Transm Dis; 2008 Apr; 35(4):346-51. PubMed ID: 18360317
[TBL] [Abstract][Full Text] [Related]
70. Imiquimod cream in the treatment of actinic keratoses.
Persaud A; Lebwohl M
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
[TBL] [Abstract][Full Text] [Related]
71. Anecdotal reports of 3 cases illustrating a spectrum of resistant common warts treated with cryotherapy followed by topical imiquimod and salicylic acid.
Housman TS; Jorizzo JL
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S217-20. PubMed ID: 12271281
[TBL] [Abstract][Full Text] [Related]
72. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
[TBL] [Abstract][Full Text] [Related]
73. Imiquimod 5% cream treatment for rapidly progressive genital condyloma in a 3-year-old girl.
Leclair E; Black A; Fleming N
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):e119-21. PubMed ID: 23158771
[TBL] [Abstract][Full Text] [Related]
74. Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.
Baker DA; Ferris DG; Martens MG; Fife KH; Tyring SK; Edwards L; Nelson A; Ault K; Trofatter KF; Liu T; Levy S; Wu J
Infect Dis Obstet Gynecol; 2011; 2011():806105. PubMed ID: 21876641
[TBL] [Abstract][Full Text] [Related]
75. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
Hengge UR; Cusini M
Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
[TBL] [Abstract][Full Text] [Related]
76. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
Zeng Y; Zheng YQ; Wang L
J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
[TBL] [Abstract][Full Text] [Related]
77. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum.
Hengge UR; Esser S; Schultewolter T; Behrendt C; Meyer T; Stockfleth E; Goos M
Br J Dermatol; 2000 Nov; 143(5):1026-31. PubMed ID: 11069514
[TBL] [Abstract][Full Text] [Related]
78. Cytokine induction and modifying the immune response to human papilloma virus with imiquimod.
Slade HB
Eur J Dermatol; 1998; 8(7 Suppl):13-6; discussion 20-2. PubMed ID: 10387958
[TBL] [Abstract][Full Text] [Related]
79. Imiquimod therapy for molluscum contagiosum.
Liota E; Smith KJ; Buckley R; Menon P; Skelton H
J Cutan Med Surg; 2000 Apr; 4(2):76-82. PubMed ID: 11179929
[TBL] [Abstract][Full Text] [Related]
80. Double-blind, randomized, placebo-controlled, prospective study evaluating the tolerability and effectiveness of imiquimod applied to postsurgical excisions on scar cosmesis.
Berman B; Frankel S; Villa AM; Ramirez CC; Poochareon V; Nouri K
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1399-403. PubMed ID: 16416607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
